Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Melanoma

  Free Subscription


16.04.2018

1 Ann Surg Oncol
1 BMC Cancer
1 Clin Cancer Res
1 J Surg Oncol
2 Melanoma Res
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. LI Y, Zhang J, Liu Y, Zhang B, et al
    MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells.
    BMC Cancer. 2018;18:404.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. SANLORENZO M, Vujic I, Floris A, Novelli M, et al
    BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody.
    Clin Cancer Res. 2018 Apr 12. pii: 1078-0432.CCR-17-1914.
    PubMed     Text format     Abstract available


    J Surg Oncol

  4. HUGHES T, Broucek J, Iodice G, Bommareddy PK, et al
    Metastasectomy following incomplete response to high-dose interleukin-2.
    J Surg Oncol. 2018;117:572-578.
    PubMed     Text format     Abstract available


    Melanoma Res

  5. LEE WJ, Lee YJ, Shin HJ, Won CH, et al
    Clinicopathological significance of tumor-infiltrating lymphocytes and programmed death-1 expression in cutaneous melanoma: a comparative study on clinical subtypes.
    Melanoma Res. 2018 Apr 9. doi: 10.1097/CMR.0000000000000449.
    PubMed     Text format     Abstract available

  6. SIA DIT, Thaung C, O'Hanlon-Brown C, Cohen VML, et al
    Immune privilege: failure of immunotherapy in controlling metastatic cutaneous melanoma to the eye.
    Melanoma Res. 2018 Apr 9. doi: 10.1097/CMR.0000000000000443.
    PubMed     Text format     Abstract available


    PLoS One

  7. NAGANE M, Kanai E, Shibata Y, Shimizu T, et al
    Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.
    PLoS One. 2018;13:e0195151.
    PubMed     Text format     Abstract available

  8. PRITCHARD AL, Johansson PA, Nathan V, Howlie M, et al
    Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    PLoS One. 2018;13:e0194098.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  9. KEGELMAN TP, Wu B, Das SK, Talukdar S, et al
    Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Proc Natl Acad Sci U S A. 2016 Dec 23. pii: 201616100.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: